Page last updated: 2024-11-02

oxidopamine and Brain Infarction

oxidopamine has been researched along with Brain Infarction in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, C1
Zhang, YX1
Yang, C1
Hao, F1
Chen, SS1
Hao, Q1
Lu, T1
Qu, TY1
Zhao, LR1
Duan, WM1

Other Studies

1 other study available for oxidopamine and Brain Infarction

ArticleYear
Intraventricular administration of endoneuraminidase-N facilitates ectopic migration of subventricular zone-derived neural progenitor cells into 6-OHDA lesioned striatum of mice.
    Experimental neurology, 2016, Volume: 277

    Topics: Animals; Animals, Newborn; Brain Infarction; Cell Cycle; Cell Differentiation; Cell Movement; Cell S

2016